The DOI matches its Crossref record; 222 of the 222 references it cites were found in a registry or an index.
Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 1×
“Amyloid beta (Aß) is the principal constituent of senile plaques in AD and is believed to impair neuronal function and cognition, even before the appearance of overt toxicity (Lesne et al., 2006).”
BackgroundRetractedWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
A new rating scale for Alzheimer's disease
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1356 · Cited by 4,175
Magnesium gates glutamate-activated channels in mouse central neurones
Nowak, L., Bregestovski, P., Ascher, P., Herbet, A., & Prochiantz, A. (1984) · Nature · doi:10.1038/307462a0 · Cited by 4,043
Neurodegenerative diseases and oxidative stress
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683 · cited 1×
“Increased oxidative stress (Mecocci et al., 1994; de la Torre and Stefano, 2000; Emerit et al., 2004) ; 6.”
Morris, R. G. M., Anderson, E., Lynch, G. S., & Baudry, M. (1986) · Nature · doi:10.1038/319774a0 · Cited by 3,640 · cited 2×
“…receptor channel blocker and this MOA for an anti-dementia drug is, at first sight, not easy to comprehend bearing in mind the accepted crucial permissive role of NMDA receptors in synaptic plasticity (Morris et al., 1986; Herron et al., 1986; Danysz et al., 1995; Collingridge and Bliss, 1995).”
BackgroundMonyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90210-0 · Cited by 3,535
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506 · cited 2×
“Thus, incubation of rat hippocampal slices with small diffusible Aß 1e42 oligomers (ADDLs) for 45 min prevented LTP in hippocampal slices well before any overt signs of cell degeneration (Lambert et al., 1998; Wang et al., 2002).”
BackgroundBenveniste, H., Drejer, J., Schousboe, A., & Diemer, N. H. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb05396.x · Cited by 2,859
Choi, D. W. (1992) · Journal of Neurobiology · doi:10.1002/neu.480230915 · Cited by 2,314
Memantine in Moderate-to-Severe Alzheimer's Disease
Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013128 · Cited by 2,043
Self-citationCholinesterase inhibitors for Alzheimer's disease
Birks, J. S. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005593 · Cited by 1,906
Aging, energy, and oxidative stress in neurodegenerative diseases
Beal, M. F. (1995) · Annals of Neurology · doi:10.1002/ana.410380304 · Cited by 1,440
Tariot, P. N., Farlow, M. R., Grossberg, G. T., Graham, S. M., McDonald, S., Gergel, I., & for the Memantine Study Group (2004) · JAMA · doi:10.1001/jama.291.3.317 · Cited by 1,403
Deciphering the Molecular Basis of Memory Failure in Alzheimer's Disease
Walsh, D. M., & Selkoe, D. J. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.010 · Cited by 1,207 · cited 3×
“4 and reviews by Greenamyre, 1991; Danysz et al., 2000; Danysz and Parsons, 2003; Walsh and Selkoe, 2004; Klein et al., 2004).”
BackgroundLacor, P. N., Buniel, M. C., Furlow, P. W., Sanz Clemente, A., Velasco, P. T., Wood, M., Viola, K. L., & Klein, W. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3501-06.2007 · Cited by 1,188 · cited 1×
“Subsequent consequences of this such as synaptic deterioration including loss of the spine cytoskeletal protein debrin were completely prevented by memantine at a concentration of 5 mM (Lacor et al., 2007).”
BackgroundMcShane, R., Areosa Sastre, A., & Minakaran, N. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003154.pub5 · Cited by 1,155
The Time Course of Glutamate in the Synaptic Cleft
Clements, J. D., Lester, R. A. J., Tong, G., Jahr, C. E., & Westbrook, G. L. (1992) · Science · doi:10.1126/science.1359647 · Cited by 1,087
Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease
Mecocci, P., MacGarvey, U., & Beal, M. F. (1994) · Annals of Neurology · doi:10.1002/ana.410360510 · Cited by 1,037
Neurodegenerative diseases and oxidative stress
Emerit, J., Edeas, M., & Bricaire, F. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2003.11.004 · Cited by 1,031
Novelli, A., Reilly, J. A., Lysko, P. G., & Henneberry, R. C. (1988) · Brain Research · doi:10.1016/0006-8993(88)90765-2 · Cited by 971
Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond
Lipton, S. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1958 · Cited by 909
De Felice, F. G., Velasco, P. T., Lambert, M. P., Viola, K., Fernandez, S. J., Ferreira, S. T., & Klein, W. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607483200 · Cited by 882 · cited 2×
“Similarly, memantine (5 or 10 mM) prevented oxidative stress and calcium influx produced by Aß oligomers in hippocampal neuronal cultures (De Felice et al., 2007a).”
BackgroundParsons, C. G., Danysz, W., & Quack, G. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00019-2 · Cited by 878
Self-citationElgoyhen, A. B., Vetter, D. E., Katz, E., Rothlin, C. V., Heinemann, S. F., & Boulter, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051622798 · Cited by 680
Chen, H., Pellegrini, J., Aggarwal, S., Lei, S., Warach, S., Jensen, F., & Lipton, S. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-11-04427.1992 · Cited by 629
Townsend, M., Shankar, G. M., Mehta, T., Walsh, D. M., & Selkoe, D. J. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2005.103754 · Cited by 619
Alternative excitotoxic hypotheses
Albin, R. L., & Greenamyre, J. T. (1992) · Neurology · doi:10.1212/wnl.42.4.733 · Cited by 574 · cited 1×
“For more extensive discussion of these factors (which is not the main aim of this review) the readers should refer to one of the recent reviews focusing on this aspect (Greenamyre, 1991; Albin and Greenamyre, 1992; Delatorre, 1994; Beal, 1995, 2000).”
BackgroundBarghorn, S., Nimmrich, V., Striebinger, A., Krantz, C., Keller, P., Janson, B., Bahr, M., Schmidt, M., Bitner, R. S., Harlan, J., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03407.x · Cited by 559
Orgogozo, J.-M., Rigaud, A.-S., Stöffler, A., Möbius, H.-J., & Forette, F. (2002) · Stroke · doi:10.1161/01.str.0000020094.08790.49 · Cited by 539
Wang, H.-W., Pasternak, J. F., Kuo, H., Ristic, H., Lambert, M. P., Chromy, B., Viola, K. L., Klein, W. L., Stine, W. B., Krafft, G. A., et al. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03058-x · Cited by 527
β-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease
Mattson, M. P., Barger, S. W., Cheng, B., Lieberburg, I., Smith-Swintosky, V. L., & Rydel, R. E. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90009-b · Cited by 518
Mechanism of action of memantine
JOHNSON, J., & KOTERMANSKI, S. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.09.007 · Cited by 502
Simpson, I. A., Chundu, K. R., Davies‐Hill, T., Honer, W. G., & Davies, P. (1994) · Annals of Neurology · doi:10.1002/ana.410350507 · Cited by 490
Memories of NMDA receptors and LTP
Collingridge, G. L., & Bliss, T. V. P. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)80016-u · Cited by 488
Small assemblies of unmodified amyloid β-protein are the proximate neurotoxin in Alzheimer’s disease
Klein, W. L., Stine, W. B., & Teplow, D. B. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.02.010 · Cited by 483
Energetics in the pathogenesis of neurodegenerative diseases
Beal, M. F. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01584-8 · Cited by 474
Laube, B., Hirai, H., Sturgess, M., Betz, H., & Kuhse, J. (1997) · Neuron · doi:10.1016/s0896-6273(00)81249-0 · Cited by 467
Keller, J. N., Pang, Z., Geddes, J. W., Begley, J. G., Germeyer, A., Waeg, G., & Mattson, M. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010273.x · Cited by 439
Glutamate in CNS disorders as a target for drug development: an update
Parsons, C. G., Danysz, W., & Quack, G. (1998) · Drug News & Perspectives · doi:10.1358/dnp.1998.11.9.863689 · Cited by 438
Self-citationWang, Q., Walsh, D. M., Rowan, M. J., Selkoe, D. J., & Anwyl, R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1633-03.2004 · Cited by 437
The Neuropharmacological Basis for the Use of Memantine in the Treatment of Alzheimer's Disease
Rogawski, M. A., & Wenk, G. L. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00254.x · Cited by 436
Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers
De Felice, F. G., Wu, D., Lambert, M. P., Fernandez, S. J., Velasco, P. T., Lacor, P. N., Bigio, E. H., Jerecic, J., Acton, P. J., Shughrue, P. J., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.02.029 · Cited by 432
Sucher, N., Akbarian, S., Chi, C., Leclerc, C., Awobuluyi, M., Deitcher, D., Wu, M., Yuan, J., Jones, E., & Lipton, S. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06509.1995 · Cited by 420
Frequency-dependent involvement of NMDA receptors in the hippocampus: a novel synaptic mechanism
Herron, C. E., Lester, R. A. J., Coan, E. J., & Collingridge, G. L. (1986) · Nature · doi:10.1038/322265a0 · Cited by 410
Danysz, W., & Parsons, C. G. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.938 · Cited by 404
Self-citationWilcock, G., M??bius, H. J., & St??ffler, A. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200211000-00005 · Cited by 381
Self-citationMemantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels
Bormann, J. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90385-3 · Cited by 351
Efficacy and Safety of Cholinesterase Inhibitors in Alzheimer’s Disease: A Meta-analysis
Lane, C. E., & Conroy, M. L. (2022) · Essential Reviews in Geriatric Psychiatry · doi:10.1007/978-3-030-94960-0_53 · Cited by 324
Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents — preclinical studies
Danysz, W., Parsons, C. G., Kornhuber, J., Schmidt, W. J., & Quack, G. (1997) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(96)00037-1 · Cited by 322
Self-citationTherapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines
Rogawski, M. A. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90005-5 · Cited by 313
Parsons, C. G., Quack, G., Bresink, I., Baran, L., Przegalinski, E., Kostowski, W., Krzascik, P., Hartmann, S., & Danysz, W. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00092-k · Cited by 311
Self-citationEvidence that Alzheimer’s disease is a microvascular disorder: the role of constitutive nitric oxide
de la Torre, J. C., & Stefano, G. B. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00043-6 · Cited by 308
Memantine Treatment in Mild to Moderate Alzheimer Disease: A 24-Week Randomized, Controlled Trial
Peskind, E. R., Potkin, S. G., Pomara, N., Ott, B. R., Graham, S. M., Olin, J. T., & McDonald, S. (2006) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000224350.82719.83 · Cited by 307
Globus, M. Y. ‐., Busto, R., Martinez, E., Valdés, I., Dietrich, W. D., & Ginsberg, M. D. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb03775.x · Cited by 299
Motherhood improves learning and memory
Kinsley, C. H., Madonia, L., Gifford, G. W., Tureski, K., Griffin, G. R., Lowry, C., Williams, J., Collins, J., McLearie, H., & Lambert, K. G. (1999) · Nature · doi:10.1038/45957 · Cited by 296
Walsh, D. M., Townsend, M., Podlisny, M. B., Shankar, G. M., Fadeeva, J. V., Agnaf, O. E., Hartley, D. M., & Selkoe, D. J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4391-04.2005 · Cited by 286
Chen, H. S., & Lipton, S. A. (1997) · The Journal of Physiology · doi:10.1113/jphysiol.1997.sp021909 · Cited by 282
Parsons, C. G., Gruner, R., Rozental, J., Millar, J., & Lodge, D. (1993) · Neuropharmacology · doi:10.1016/0028-3908(93)90029-3 · Cited by 279
Self-citationDanysz, W., Parsons, C. G., MÖbius, H.-J., StÖffler, A., & Quack, G. (2000) · Neurotoxicity Research · doi:10.1007/bf03033787 · Cited by 263
Self-citationLipton, S. (2005) · Current Alzheimer Research · doi:10.2174/1567205053585846 · Cited by 256
Kennedy, A. M., Frackowiak, R. S. J., Newman, S. K., Bloomfield, P. M., Seaward, J., Roques, P., Lewington, G., Cunningham, V. J., & Rossor, M. N. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11270-7 · Cited by 250
Trapping Channel Block of NMDA-Activated Responses By Amantadine and Memantine
Blanpied, T. A., Boeckman, F. A., Aizenman, E., & Johnson, J. W. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.77.1.309 · Cited by 249
Floden, A. M., Li, S., & Combs, C. K. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4998-04.2005 · Cited by 246
Brewer, G. J., & Wallimann, T. W. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741968.x · Cited by 230
Harris, M. E., Wang, Y., Pedigo, N. W., Hensley, K., Butterfield, D. A., & Carney, J. M. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67010277.x · Cited by 230
Alessandri-Haber, N., Dina, O. A., Joseph, E. K., Reichling, D., & Levine, J. D. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5385-05.2006 · Cited by 228
Takeda, A., Loveman, E., Clegg, A., Kirby, J., Picot, J., Payne, E., & Green, C. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1402 · Cited by 227
Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment
Cummings, J. L., Schneider, E., Tariot, P. N., & Graham, S. M. (2006) · Neurology · doi:10.1212/01.wnl.0000223333.42368.f1 · Cited by 223
Hirai, H., Kirsch, J., Laube, B., Betz, H., & Kuhse, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.6031 · Cited by 223
Kornhuber, J., & Weller, M. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00047-9 · Cited by 222
Gauthier, S., Wirth, Y., & Möbius, H. J. (2005) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1341 · Cited by 206
Synaptic plasticity in animal models of early Alzheimer's disease
Rowan, M. J., Klyubin, I., Cullen, W. K., & Anwyl, R. (2003) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2002.1240 · Cited by 203
Chen, H.-S. V., Wang, Y. F., Rayudu, P. V., Edgecomb, P., Neill, J. C., Segal, M. M., Lipton, S. A., & Jensen, F. E. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00163-8 · Cited by 202
Aracava, Y., Pereira, E. F. R., Maelicke, A., & Albuquerque, E. X. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.077172 · Cited by 200
Rammes, G., Rupprecht, R., Ferrari, U., Zieglgänsberger, W., & Parsons, C. G. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01872-9 · Cited by 200
Self-citationNMDA Receptor Activation Inhibits α-Secretase and Promotes Neuronal Amyloid-β Production
Lesné, S., Ali, C., Gabriel, C., Croci, N., MacKenzie, E. T., Glabe, C. G., Plotkine, M., Marchand-Verrecchia, C., Vivien, D., & Buisson, A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0849-05.2005 · Cited by 199
BLASS, J. P., SHEU, R. K., & GIBSON, G. E. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06370.x · Cited by 199
Abraham, W. C., & Mason, S. E. (1988) · Brain Research · doi:10.1016/0006-8993(88)90582-3 · Cited by 198
Hoyer, S., Nitsch, R., & Oesterreich, K. (1991) · Journal of Neural Transmission - Parkinson's Disease and Dementia Section · doi:10.1007/bf02251132 · Cited by 196
Wang, Q., Rowan, M. J., & Anwyl, R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0233-04.2004 · Cited by 193
Glutamate antagonists have different effects on spontaneous locomotor activity in rats
Danysz, W., Essmann, U., Bresink, I., & Wilk, R. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90506-1 · Cited by 189
Self-citationLi, J. H., Wang, Y. H., Wolfe, B. B., Krueger, K. E., Corsi, L., Stocca, G., & Vicini, S. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00169.x · Cited by 186
A mitochondrial DNA clone is associated with increased risk for Alzheimer disease.
Hutchin, T., & Cortopassi, G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.6892 · Cited by 186
Modulation of learning processes by ionotropic glutamate receptor ligands
Danysz, W., Zajaczkowski, W., & Parsons, C. G. (1995) · Behavioural Pharmacology · doi:10.1097/00008877-199508000-00007 · Cited by 185
Self-citationMemantine Improves Spatial Learning in a Transgenic Mouse Model of Alzheimer’s Disease
Minkeviciene, R., Banerjee, P., & Tanila, H. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.071027 · Cited by 184
Kim, J.-H., Anwyl, R., Suh, Y.-H., Djamgoz, M. B. A., & Rowan, M. J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-04-01327.2001 · Cited by 182
The role of mitochondria in inherited neurodegenerative diseases
Kwong, J. Q., Beal, M. F., & Manfredi, G. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03990.x · Cited by 180 · cited 1×
“Mitochondrial dysfunctions (Blanchard et al., 1993; Mecocci et al., 1994; Hutchin and Cortopassi, 1995; Hoyer, 1996; Kwong et al., 2006); 2.”
BackgroundExcitotoxic index — a biochemical marker of selective vulnerability
Globus, M. Y.-T., Ginsberg, M. D., & Busto, R. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90889-2 · Cited by 180
Open-Channel Blockers at the Human α4β2 Neuronal Nicotinic Acetylcholine Receptor
Buisson, B., & Bertrand, D. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.3.555 · Cited by 179
Chen, Q.-S., Wei, W.-Z., Shimahara, T., & Xie, C.-W. (2002) · Neurobiology of Learning and Memory · doi:10.1006/nlme.2001.4034 · Cited by 176
Memories of NMDA receptors and LTP
Collingridge, G. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93868-x · Cited by 175
Hoyer, S. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00156-x · Cited by 174
Freir, D. B., Hölscher, C., & Herron, C. E. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.85.2.708 · Cited by 167
Burns, A. S., O'Brien, J. T., Auriacombe, S., Ballard, C., Broich, K., Bullock, R., Feldman, H., Ford, G., Knapp, M., McCaddon, A., et al. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106068299 · Cited by 167
Developmental Regulation of Nicotinic Synapses on Cochlear Inner Hair Cells
Katz, E., Elgoyhen, A. B., Gómez-Casati, M. E., Knipper, M., Vetter, D. E., Fuchs, P. A., & Glowatzki, E. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2102-04.2004 · Cited by 162
Katagiri, H., Tanaka, K., & Manabe, T. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01664.x · Cited by 159
Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide
Noda, M., Nakanishi, H., & Akaike, N. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00036-6 · Cited by 158
Kornhuber, J., & Quack, G. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11785-u · Cited by 156
Low-frequency activation of the NMDA receptor system can prevent the induction of LTP
Coan, E. J., Irving, A. J., & Collingridge, G. L. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90038-4 · Cited by 156
Wenk, G. L., Parsons, C. G., & Danysz, W. (2006) · Behavioural Pharmacology · doi:10.1097/00008877-200609000-00007 · Cited by 154
Self-citationBarnes, C. A., Danysz, W., & Parsons, C. G. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01241.x · Cited by 149
Self-citationHoyer, S., & Nitsch, R. M. (1989) · Journal of Neural Transmission · doi:10.1007/bf01258634 · Cited by 146
Porter, R. H. P., & Greenamyre, J. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020614.x · Cited by 146
The Adamantyl Group in Medicinal Agents. I. Hypoglycemic N-Arylsulfonyl-N'-adamantylureas
Gerzon, K., Krumkalns, E. V., Brindle, R. L., Marshall, F. J., & Root, M. A. (1963) · Journal of Medicinal Chemistry · doi:10.1021/jm00342a029 · Cited by 142
Low Doses of Memantine Disrupt Memory in Adult Rats
Creeley, C. E., Wozniak, D. F., Labruyere, J., Taylor, G. T., & Olney, J. W. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4883-05.2006 · Cited by 139
Dam, D. V., Abramowski, D., Staufenbiel, M., & Deyn, P. P. D. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2132-z · Cited by 139
Cl−-ATPase and Na+/K+-ATPase activities in Alzheimer's disease brains
Hattori, N., Kitagawa, K., Higashida, T., Yagyu, K., Shimohama, S., Wataya, T., Perry, G., Smith, M. A., & Inagaki, C. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00654-5 · Cited by 137
Frankiewicz, T., Potier, B., Bashir, Z. I., Collingridge, G. L., & Parsons, C. G. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15245.x · Cited by 135
Self-citationβ‐amyloid inhibition of long‐term potentiation is mediated via tumor necrosis factor
Wang, Q., Wu, J., Rowan, M. J., & Anwyl, R. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04457.x · Cited by 134
Banerjee, P., Samoriski, G., & Gupta, S. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.081976 · Cited by 134
Parsons, C. G., Danysz, W., Bartmann, A., Spielmanns, P., Frankiewicz, T., Hesselink, M. B., Eilbacher, B., & Quack, G. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00161-0 · Cited by 133
Self-citationBrorson, J. R., Bindokas, V. P., Iwama, T., Marcuccilli, C. J., Chisholm, J. C., & Miller, R. J. (1995) · Journal of Neurobiology · doi:10.1002/neu.480260305 · Cited by 129
β-Amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus
Wu, J., Anwyl, R., & Rowan, M. J. (1995) · Neuroreport · doi:10.1097/00001756-199511270-00031 · Cited by 128
Ditzler, K. (1991) · PubMed · Cited by 127
Zoladz, P. R., CAMPBELL, A., Park, C. R., Schaefer, D., Danysz, W., & Diamond, D. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.08.011 · Cited by 127
Self-citationWillard, L. B., Hauss‐Wegrzyniak, B., Danysz, W., & Wenk, G. L. (2000) · Experimental Brain Research · doi:10.1007/s002210000446 · Cited by 126
Self-citationAlzheimer Disease: from Molecular Biology to Therapy
Giacobini, E. (1997) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(97)85593-x · Cited by 120
The inhibitory effects of β-amyloid on glutamate and glucose uptakes by cultured astrocytes
Parpura‐Gill, A., Beitz, D. C., & Uemura, E. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00043-7 · Cited by 120
Impaired brain microcirculation may trigger Alzheimer's disease
de la Torre, J. C. (1994) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(94)90052-3 · Cited by 120
Disease modifying therapy for AD?1
Golde, T. E. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04211.x · Cited by 117
Bresink, I., Danysz, W., Parsons, C. G., & Mutschler, E. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00017-z · Cited by 117
Self-citationB- Amyloid increases neuronal susceptibility to injufy by glucose deprivation
Copani, A., Koh, J., & Cotman, C. W. (1991) · Neuroreport · doi:10.1097/00001756-199112000-00008 · Cited by 117
Parsons, C. G., Panchenko, V. A., Pinchenko, V. O., Tsyndrenko, A. Y., & Krishtal, O. A. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01228.x · Cited by 114
Self-citationMielke, R., Herholz, K., Grond, M., Kessler, J., & Heiß, W.-D. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90015-p · Cited by 113
Zajaczkowski, W., Frankiewicz, T., Parsons, C. G., & Danysz, W. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00070-1 · Cited by 112
Self-citationZajaczkowski, W., Quack, G., & Danysz, W. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00716-4 · Cited by 110
Self-citationFrankiewicz, T., & Parsons, C. G. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00060-x · Cited by 110
Self-citationThe benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer’s disease
Thompson, S., Lanctôt, K. L., & Herrmann, N. (2004) · Expert Opinion on Drug Safety · doi:10.1517/14740338.3.5.425 · Cited by 109
DANTOINE, T. F., Auriacombe, S., Sarazin, M., Becker, H., Pere, J.-J., & Bourdeix, I. (2005) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2005.00769.x · Cited by 108
Misztal, M., Frankiewicz, T., Parsons, C. G., & Danysz, W. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00682-6 · Cited by 103
Self-citationEffects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells
Bresink, I., Benke, T. A., Collett, V. J., Seal, A., Parsons, C. G., Henley, J. M., & Collingridge, G. L. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15971.x · Cited by 102
Self-citationMitani, A., Andou, Y., & Kataoka, K. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90492-k · Cited by 99
Davies, S. N., MARTIN, D. F., Millar, J. D., Aram, J. A., Church, J., & Lodge, D. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90225-7 · Cited by 99
NMDA receptor regulation by amyloid-β does not account for its inhibition of LTP in rat hippocampus
Raymond, C. R., Ireland, D. R., & Abraham, W. C. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02269-8 · Cited by 96
Spanagel, R., Eilbacher, B., & Wilke, R. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90023-x · Cited by 94
Rowan, M. J., Klyubin, I. V., Wang, Q., & Anwyl, R. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330563 · Cited by 93
Furukawa, K., & Mattson, M. P. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00398-9 · Cited by 93
Si, A., Helliwell, P. G., & Maleszka, R. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.09.023 · Cited by 90
Efficacy and Safety of Memantine in Moderate-to-Severe Alzheimer Disease: The Evidence to Date
Bullock, R. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000201847.29836.a5 · Cited by 89 · cited 1×
“Rogawski and Wenk, 2003; Lipton, 2006; Wenk et al., 2006; Bullock, 2006).”
Sobolevsky, A. I., Koshelev, S. G., & Khodorov, B. I. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.047bf.x · Cited by 89
Coan, E. J., & Collingridge, G. L. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90192-8 · Cited by 89
Oxidative metabolism deficiencies in brains of patients with Alzheimer's disease
Hoyer, S. (1996) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1996.tb05868.x · Cited by 88 · cited 3×
“Decrease in glucose metabolism/supply (Hoyer et al., 1991; Mielke et al., 1992; Goto et al., 1993; Simpson et al., 1994; Kennedy et al., 1995; Hoyer, 1996; ParpuraGill et al., 1997).”
BackgroundTolerability of memantine in combination with cholinesterase inhibitors in dementia therapy
Hartmann, S., & bius, H. J. R. M. (2003) · International Clinical Psychopharmacology · doi:10.1097/00004850-200303000-00003 · Cited by 88
Striatal Protection Induced by Lesioning the Substantia Nigra of Rats Subjected to Focal Ischemia
Buisson, A., Callebert, J., Mathieu, E., et al. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08358.x · Cited by 86
Maskell, P., Spéder, P., Newberry, N. R., & Bermúdez, I. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705559 · Cited by 84
Yamada, K., Takayanagi, M., Kamei, H., Nagai, T., Dohniwa, M., Kobayashi, K., Yoshida, S., Oh-hara, T., Takauma, K., & Nabeshima, T. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.02.036 · Cited by 84
Unsuspected Morbid Hypermagnesemia in Elderly Patients
Clark, B. A., & Brown, R. S. (1992) · American Journal of Nephrology · doi:10.1159/000168469 · Cited by 82
A cohort study of effectiveness of acetylcholinesterase inhibitors in Alzheimer’s disease
Raschetti, R., Maggini, M., Sorrentino, G. C., Martini, N., Caffari, B., & Vanacore, N. (2005) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-005-0946-1 · Cited by 82
Ye, C., Walsh, D. M., Selkoe, D. J., & Hartley, D. M. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.05.060 · Cited by 80
Lack of Pharmacokinetic or Pharmacodynamic Interaction Between Memantine and Donepezil
Periclou, A. P., Ventura, D., Sherman, T., Rao, N. S., & Abramowitz, W. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d638 · Cited by 79
Dysregulation of Na+/K+ ATPase by amyloid in APP+PS1 transgenic mice
Dickey, C. A., Gordon, M. N., Wilcock, D. M., Herber, D. L., Freeman, M. J., & Morgan, D. (2005) · BMC Neuroscience · doi:10.1186/1471-2202-6-7 · Cited by 78
Landfield, P. W., & Morgan, G. A. (1984) · Brain Research · doi:10.1016/0006-8993(84)91199-5 · Cited by 78
Cognitive evaluation of disease-modifying efficacy of Galantamine and Memantine in the APP23 model
Dam, D. V., & Deyn, P. P. D. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.06.005 · Cited by 78
The role of neuronal energy in the neurotoxicity of excitatory amino acids
Henneberry, R. C. (1989) · Neurobiology of Aging · doi:10.1016/0197-4580(89)90149-8 · Cited by 76
Hesselink, M. B., de Boer, B. G., Breimer, D. D., & Danysz, W. (1999) · Pharmaceutical Research · doi:10.1023/a:1018856020583 · Cited by 72
Self-citationLipton, S. A., & Chen, H.-S. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401344 · Cited by 72
Avenet, P., Léonardon, J., Besnard, F., Graham, D., Depoortere, H., & Scatton, B. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)13422-x · Cited by 68
Vignini, A., Nanetti, L., Moroni, C., Tanase, L., Bartolini, M., Luzzi, S., Provinciali, L., & Mazzanti, L. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.010 · Cited by 68
Mechanism of membrane depolarization caused by the Alzheimer Aβ1–42 peptide
Blanchard, B. J., Thomas, V. L., & Ingram, V. M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00346-7 · Cited by 68
Mechanisms of the inhibitory effects of amyloid β-protein on synaptic plasticity
Rowan, M. J., Klyubin, I. V., Wang, Q., & Anwyl, R. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.06.020 · Cited by 65
Lipton, S. A. (2004) · Nature · doi:10.1038/428473a · Cited by 64
The NMDA antagonist memantine impairs classical eyeblink conditioning in humans
Schugens, M. M., Egerter, R., Daum, I., Schepelmann, K., Klockgether, T., & Löschmann, P. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)13452-8 · Cited by 64
Kew, J. N. C., Trube, G., & Kemp, J. A. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701634 · Cited by 64
[3H]MK-801 binding sites in post-mortem human frontal cortex
Kornhuber, J., Mack-Burkhardt, F., Kornhuber, M. E., & Riederer, P. F. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90339-7 · Cited by 63
Schmitt, F. A., van Dyck, C. H., Wichems, C. H., & Olin, J. T. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213860.35355.d4 · Cited by 62
Evaluation of memantine for the treatment of Alzheimer?s disease
Ferris, S. H. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.12.2305 · Cited by 62
van Dyck, C. H., Schmitt, F. A., & Olin, J. T. (2006) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000203151.17311.38 · Cited by 62
Costello, D. A., & Herron, C. E. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.11.016 · Cited by 61
Effects of Pharmacologically Induced Changes in NMDA-Receptor Activity on Long-Term Memory in HumansPreprint
Rammsayer, T. H. (2001) · Learning & Memory · doi:10.1101/lm.33701 · Cited by 61
Two Blocking Sites of Amino-Adamantane Derivatives in Open N-Methyl-d-Aspartate Channels
Sobolevsky, A. I., & Koshelev, S. G. (1998) · Biophysical Journal · doi:10.1016/s0006-3495(98)77844-0 · Cited by 60
Nakamura, S., Murayama, N., Noshita, T., Katsuragi, R., & Ohno, T. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.07.049 · Cited by 60
Dizocilpine-like Discriminative Stimulus Effects of Low-affinity Uncompetitive NMDA Antagonists
Grant, K. A., Colombo, G., GRANT, J., & Rogawski, M. A. (1996) · Neuropharmacology · doi:10.1016/s0028-3908(96)00147-5 · Cited by 59
Amyloid Protein Precursor Stimulates Excitatory Amino Acid Transport
Masliah, E., Raber, J., Alford, M. F., Mallory, M. E., Mattson, M. P., Yang, D., Wong, D. T., & Mucke, L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.12548 · Cited by 59
Low concentrations of inhibit the induction of long-term potentiation in rat hippocampal slices
Izumi, Y., Clifford, D. B., & Zorumski, C. F. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90414-3 · Cited by 58
CARVALHO, F., PEREIRA, S., Pires, R. G. W., Ferraz, V. P., Romano‐Silva, M. A., Silva, I. D. F. O., & Ribeiro, Â. M. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.03.004 · Cited by 57
Glick, J. L. (1990) · Medical Hypotheses · doi:10.1016/0306-9877(90)90095-v · Cited by 56
Disturbances of magnesium concentrations in various brain areas in Alzheimer's disease.
Andrási, E., Igaz, S., Molnár, Z., & Makó, S. (2000) · PubMed · Cited by 54
The effects of mitochondrial failure upon cholinergic toxicity in the nucleus basalis
Wenk, G. L., Danysz, W., & Roice, D. (1996) · Neuroreport · doi:10.1097/00001756-199606170-00001 · Cited by 54
Self-citationDoody, R., Wirth, Y., Schmitt, F., & Möbius, H. J. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000079833 · Cited by 52
Quack, G., Hesselink, M. B., Danysz, W., & Spanagel, R. (1995) · Journal of Neural Transmission · Cited by 51
Self-citationFranceschi, M., Alberoni, M., Bressi, S., Canal, N., Comı, G., Fazio, F., Grassi, F., Perani, D., & Volonté, M. A. (1995) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106919 · Cited by 50
A mitochondrial DNA deletion in normally aging and in Alzheimer brain tissue
Blanchard, B. J., Park, T., Fripp, W. J., Lerman, L. S., & Ingram, V. M. (1993) · Neuroreport · doi:10.1097/00001756-199306000-00051 · Cited by 49
Ye, L., & Qiao, J. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00795-8 · Cited by 48
Investigations of neurotoxicity and neuroprotection within the nucleus basalis of the rat
Wenk, G. L., Danysz, W., & Mobley, S. L. (1994) · Brain Research · doi:10.1016/0006-8993(94)91590-3 · Cited by 48
Self-citationHallak, M. (1998) · PubMed · Cited by 47
Measuring cognition in advanced Alzheimer’s disease for clinical trials
Schmitt, F. A., Locke, D. E. C., Ashford, J. W., Reisberg, ., Ferris, S. H., Möbius, H. J., & Stöffler, A. (2002) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6139-5_14 · Cited by 44
Self-citationAlzheimer's disease risk factors as related to cerebral blood flow
Crawford, J. G. (1996) · Medical Hypotheses · doi:10.1016/s0306-9877(96)90189-9 · Cited by 44
Magnesium depletion and pathogenesis of Alzheimer's disease.
Durlach, J. (1990) · PubMed · Cited by 43
Positron emission tomographic (PET) studies in dementia
Goto, I., Taniwaki, T., Hosokawa, S., Otsuka, M., Ichiya, Y., & Ichimiya, A. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90040-6 · Cited by 42
Honegger, U. E., Quack, G., & WIESMANN, U. N. (1993) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1993.tb01564.x · Cited by 42
Magnesium deficiency impairs fear conditioning in mice
Bardgett, M. E., Schultheis, P. J., McGill, D. L., Richmond, R. E., & Wagge, J. (2005) · Brain Research · doi:10.1016/j.brainres.2005.01.020 · Cited by 42
Neuroprotective and Cognition‐Enhancing Properties of MK‐801 Flexible Analogs
Бачурин, С. О., Tkachenko, S. N., Baskin, I. I., Lermontova, N. N., Mukhina, T. V., Petrova, L. N., Устинов, А. К., Proshin, A. N., Grigoriev, V. V., Lukoyanov, N., et al. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03629.x · Cited by 41
Wary, Brillault‐Salvat, Bloch, Leroy‐Willig, Roumenov, Grognet, Leclerc, & Carlier (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00063.x · Cited by 40
Nomura, I., Kato, N., Kita, T., & Takechi, H. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.08.024 · Cited by 40
Magnesium supplementation in the treatment of dementia patients
Öztürk, Ş., & Çilliler, A. E. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.04.047 · Cited by 39
Nankai, M., Klarica, M., Fage, D., & Carter, C. (1998) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(97)00180-2 · Cited by 38
Distribution and Metabolism of the Potential Anti-Parkinson Drng Memantine in the Human
Wesemann, W., Sturm, G., & Fünfgeld, E. W. (1980) · Springer eBooks · doi:10.1007/978-3-7091-8582-7_15 · Cited by 37
Ladner, C. J., & Lee, J. M. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7116 · Cited by 37
Neuronal bioenergetic defects, excitotoxicity and Alzheimer's disease: “Use it and lose it”
Greenamyre, J. T. (1991) · Neurobiology of Aging · doi:10.1016/0197-4580(91)90012-9 · Cited by 37
Cited by
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
Paoletti, P., Bellone, C., & Zhou, Q. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3504 · Cited by 2,523
The Lipophilic Bullet Hits the Targets: Medicinal Chemistry of Adamantane Derivatives
Wanka, L., Iqbal, K., & Schreiner, P. R. (2013) · Chemical Reviews · doi:10.1021/cr100264t · Cited by 696
The Role of NMDA Receptors in Alzheimer’s Disease
Liu, J., Chang, L., Song, Y., Li, H., & Wu, Y. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00043 · Cited by 535
Milnerwood, A. J., Gladding, C. M., Pouladi, M. A., Kaufman, A. M., Hines, R. M., Boyd, J. D., Ko, R. W. Y., Vasuta, O. C., Graham, R. K., Hayden, M. R., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.01.008 · Cited by 517
Danysz, W., & Parsons, C. G. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02057.x · Cited by 500
Self-citation
Metadata
- Authors
- Parsons, C. G., Stöffler, A., & Danysz, W.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2007-11
- Volume
- 53
- Issue
- 6
- Pages
- 699-723
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2114163624
- Cited by
- 707
- References
- 222
- FWCI
- 16.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.